vimarsana.com
Home
Live Updates
FDA's New Guidance Proposes Flexible Use of AI in Medical De
FDA's New Guidance Proposes Flexible Use of AI in Medical De
FDA's New Guidance Proposes Flexible Use of AI in Medical Devices | Foley & Lardner LLP
On April 3, 2023, U.S. Food and Drug Administration (FDA) issued its much anticipated draft guidance, "Marketing Submission Recommendations for a Predetermined Change Control Plan for...
Related Keywords
United Kingdom ,
Canada ,
,
Foley Lardner ,
Regulatory Agency ,
Health Canada ,
Ai Software ,
Drug Administration ,
Device Software Functions Draft Guidance ,
Submission Recommendations ,
Predetermined Change Control Plan ,
Machine Learning ,
Enabled Device Software ,
Draft Guidance ,
Medical Device Action Plan ,
Predetermined Change Control ,
Medical Device ,
Good Machine Learning Practice ,